BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7998124)

  • 1. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
    Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
    Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
    Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443).
    Räisänen-Sokolowski A; Aho P; Myllärniemi M; Kallio E; Häyry P
    Transplant Proc; 1995 Feb; 27(1):435. PubMed ID: 7879051
    [No Abstract]   [Full Text] [Related]  

  • 5. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
    Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
    [No Abstract]   [Full Text] [Related]  

  • 6. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
    Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
    MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T
    Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
    Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat.
    Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H
    J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
    Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST
    Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
    Belitsky P; Gulanikar A; He G; Gupta R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
    [No Abstract]   [Full Text] [Related]  

  • 12. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and experimental chronic allograft rejection.
    Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen A; Koskinen P; Ustinov J; Lautenschalger I; Taskinen E
    Transplant Proc; 1994 Jun; 26(3):1702-3. PubMed ID: 8030092
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
    Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J
    Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of 15-deoxyspergualin on allograft arterio-sclerosis and growth factor synthesis in the rat.
    Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
    Transpl Int; 1994; 7 Suppl 1():S376-7. PubMed ID: 11271256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effects of FK 506 and 15-deoxyspergualin in rat lung transplantation.
    Katayama Y; Takao M; Onoda K; Hiraiwa T; Yada I; Namikawa S; Kusagawa M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):349-53. PubMed ID: 1703690
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualin.
    Schorlemmer HU; Dickneite G; Seiler FR
    Transplant Proc; 1990 Aug; 22(4):1626-30. PubMed ID: 2389427
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
    Mennander A; Räisänen A; Paavonen T; Häyry P
    Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection.
    Mennander A; Paavonen T; Häyry P
    Transplant Proc; 1992 Feb; 24(1):341. PubMed ID: 1539306
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat.
    Geerling RA; de Bruin RW; Scheringa M; Bonthuis F; Jeekel J; Ijzermans JN; Marquet RL
    Transplantation; 1994 Dec; 58(11):1258-63. PubMed ID: 7992371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.